RLMDRelmada Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 21027
Ticker: RLMD
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-03-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RLMD

Detail

Enriched 2026-08-14 20:47

Market cap: $503,481,673.12
Shares outstanding (class): 106,669,846
Shares outstanding (weighted): 106,669,846
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 17
Location: CORAL GABLES, FL
Homepage: https://www.relmada.com
Description: Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Market cap and share counts drift.

Funds holding this security

10 funds · 10 positions · $24.18M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$15.17M	0.00%	2,180,304 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$5.74M	0.01%	824,977 NS	FIGI
AdvisorShares Psychedelics ETF AdvisorShares Trust	PSIL	$2.06M	10.17%	295,872 NS	FIGI
SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST	—	$633.9K	0.09%	91,078 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$268.6K	0.00%	38,589 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$224.5K	0.00%	32,256 NS	FIGI
TIFF MULTI-ASSET FUND TIFF Investment Program	—	$40.5K	0.00%	5,817 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$25.8K	0.00%	3,700 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$8.6K	0.00%	1,236 NS	FIGI
State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST	—	$4.3K	0.00%	620 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRLMD
FIGI_COMPOSITEBBG003MKSL16
FIGI_SHARE_CLASSBBG003MKSL25
CIK0001553643
ISINUS75955J4022
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC code 2834 indicates pharmaceutical preparations, so the security is an equity in the healthcare pharmaceuticals industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.